Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Slides:

Advertisements

Similar presentations

The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates Anthony Castleberry, MD, MMCI, Michael S. Mulvihill,

Advertisements

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Elizabeth A. David, MD, David T

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Benny Weksler, MD, Jennifer L. Sullivan, MD

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Chun Chieh Lin, PhD, MBA, Matthew P

Joshua E. Rosen, BASc, Hari B

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Trevor Williams, MD, MPH, Brian C

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Double-Lung Transplantation Can Be Safely Performed Using Donors With Heavy Smoking History Sharven Taghavi, MD, MPH, Senthil Jayarajan, MD, Eugene Komaroff,

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Loretta Erhunmwunsee, MD, Brian C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Trevor Williams, MD, MPH, Brian C

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

The Impact of Dominant Ventricle Morphology on Palliation Outcomes of Single Ventricle Anomalies Bahaaldin Alsoufi, MD, Scott Gillespie, MS, Dennis Kim,

A Comparative Analysis of Bronchial Stricture After Lung Transplantation in Recipients With and Without Early Acute Rejection Anthony W. Castleberry,

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy

Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral? Elliot Wakeam, MD, MPH, Joseph.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Acute Kidney Injury Increases Mortality After Lung Transplantation

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Assessment of Different Threshold Preoperative Glomerular Filtration Rates as Markers of Outcomes in Lung Transplantation Asishana A. Osho, MPH, Anthony.

Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

William M. Whited, MD, Paul Henley, BS, Erin M

Antegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: Does it matter? A propensity-matched.

Medication Nonadherence After Lung Transplantation in Adult Recipients

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? Asvin M. Ganapathi,

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Presentation transcript:

The Effect of Prior Pneumonectomy or Lobectomy on Subsequent Lung Transplantation Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W. Castleberry, MD, MMCi, Brian R. Englum, MD, Asishana A. Osho, MPH, R. Duane Davis, MD, MBA, Matthew G. Hartwig, MD The Annals of Thoracic Surgery Volume 98, Issue 6, Pages 1922-1929 (December 2014) DOI: 10.1016/j.athoracsur.2014.06.042 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Number of patients with prior major thoracic surgery, lobectomy (gray bars) or pneumonectomy (black bars) receiving a lung transplant stratified by year of surgery. (∗ Indicates data from 10/1999–12/1999 only.) The Annals of Thoracic Surgery 2014 98, 1922-1929DOI: (10.1016/j.athoracsur.2014.06.042) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier survival curve of resection (RESXN) patients (blue line) and propensity-matched nonresection (non-RESXN) patients (red line). Numbers of patients at risk are shown at bottom of figure. The Annals of Thoracic Surgery 2014 98, 1922-1929DOI: (10.1016/j.athoracsur.2014.06.042) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions